AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript [The Motley Fool]
Last acelrx pharmaceuticals, inc. earnings: 3/16 07:35 am
Check Earnings Report
US:NASDAQ Investor Relations: ir.acelrx.com/investor-relations
AcelRx Pharmaceuticals Inc (ACRX) Q2 2019 Earnings Call Transcript -- The Motley Fool AcelRx Pharmaceuticals Inc (ACRX) Q 09 Earnings Call Transcript ACRX earnings call for the period ending June 0, 09. MFTranscribers Image source: The Motley Fool. NASDAQ:ACRX Aug , 09 :00 p.m. ET Contents: : Operator Welcome to the AcelRx Second Quarter 09 Conference Call. This call is being webcast live on the Events page of the Investors section of AcelRx's website at acelrx.com. This call is the property of AcelRx and any recording, reproduction, or transmission of this call without the express written consent of AcelRx is strictly prohibited. [Operator Instructions] You may listen to a webcast replay of this call by going to the Investors section of Acel's website. I would like to now turn the call over to Raffi Asadorian, AcelRx's Chief Financial Officer. Thank you. And thank you for joining us this afternoon. Earlier today, we reported our second quarter 09 financial results and provided an
[Read more]
| Impact snapshot | Event time: | ACRX | ||||
|---|---|---|---|---|---|---|
|
Last Price
|
Price Change
|
Price Change %
|
Volume Shares
|
Max Up
|
Max Down
|
Volume Ratio
%
|
Performance comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last price | ||
| VWAP | ||
|
High:
|
Max up |
High:
|
|
Low:
|
Max down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event Day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance Since Event
Time and Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
SIGN UP TODAY
Opt-in for
ACRX alerts
ACRX alerts
from News Quantified
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ACRX alerts
High impacting AcelRx Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ACRX
News
- AcelRx Pharmaceuticals to Participate in Two September Investor ConferencesPR Newswire
- Study Results Announced During Award-Winning Presentation on the Effect of Sufentanil Sublingual Tablet on Outpatient Plastic Surgery at the Annual Miami Cosmetic Surgery EventPR Newswire
- Presentation on the Effect of the Administration of Sufentanil Sublingual Tablet on Reducing Post-Operative Recovery Time and Opioid Use in Plastic Surgery at the Annual Miami Cosmetic Surgery EventPR Newswire
- AcelRx Pharmaceuticals, Inc. (<a href="https://www.marketbeat.com/stocks/NASDAQ/ACRX/price-target/">NASDAQ: ACRX</a>) had its price target lowered by analysts at HC Wainwright from $7.00 to $5.00. They now have a "buy" rating on the stockMarketBeat
- AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vincent Angotti on Q2 2021 Results - Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- More
ACRX
SEC Filings
- 8/18/21 - Form S-8
- 8/16/21 - Form 10-Q
- 8/16/21 - Form 8-K
- ACRX's page on the SEC website
- More